In section Releases

CentralReach Deploys AI to Shrink Administrative Burden for BCBAs

Behavior analysts spend nearly half their working hours on non-billable documentation, a reality driving widespread burnout across the autism care sector. Fort Lauderdale-based CentralReach is now attempting to reverse this trend with ReportDraftAI, a new tool designed to automate the assembly of clinical progress reports and reauthorization data.

CentralReach Deploys AI to Shrink Administrative Burden for BCBAs

The current standard for reauthorization reporting is a labor-intensive marathon. BCBAs must manually aggregate authorization details, treatment goals, and assessment data to justify medical necessity, a process that typically consumes 9 to 12 hours per learner. According to a 2025 study in Behavior Analysis in Practice, this administrative weight forces practitioners to spend 46% of their time on non-billable tasks—far exceeding the recommended 25% to 30% threshold.

ReportDraftAI functions by pulling existing patient data directly from the CentralReach platform into a structured, review-ready draft. While the software handles the clerical consolidation of service and assessment information, the company emphasizes that clinical interpretation remains the sole responsibility of the provider. The tool includes collaborative workflows for peer review and digital signatures, aiming to streamline the path from initial data gathering to final submission.

This launch expands an existing suite of clinical AI products already integrated into the CentralReach ecosystem. The company previously introduced NoteDraftAI, which has facilitated over 5.8 million session note summaries, and NoteGuardAI, a compliance tool that audited more than 3 million notes in August 2026 alone. Looking ahead, CentralReach is also testing VoiceDraftAI, a beta tool that converts natural speech into structured clinical records. These initiatives reflect a broader industry push to reclaim clinician time for direct patient care rather than data management.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!